News
12-13-2010, 02:21 AM
Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.
More... (http://www.news-medical.net/news/20101213/Prostate-cancer-study-identifies-295-genes-associated-with-clinical-recurrence-following-radical-prostatectomy.aspx)
More... (http://www.news-medical.net/news/20101213/Prostate-cancer-study-identifies-295-genes-associated-with-clinical-recurrence-following-radical-prostatectomy.aspx)